Difference between revisions of "Part:BBa K2923019:Experience"
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
===Introduction=== | ===Introduction=== | ||
− | To validate the designed constructs we decided to test | + | To validate the designed constructs we decided to test Theophylline switch-off (stop auto-cleavage in presence of ligand). For negative control, we choose an inactive form of aptazyme: mutation at the ribozyme domain. iGEM Strasbourg designed construct requires the use of aptazyme linked to MS2 and PP7 stem-loops. The following results described MS2-MS2-Aptazyme-PP7-PP7 activity in in-vitro and in-vivo assays. |
− | ===In-vitro assay of | + | ===In-vitro assay of BBa_K2923019=== |
− | In order to check MS2-MS2- | + | In order to check MS2-MS2-Theophylline-PP7-PP7 cleavage activities, in-vitro transcription products were analyzed by 2% agarose gel with urea (Figure 1). |
− | [[Image: | + | [[Image: Theo gel-2.jpg|300px|thumb|center| Figure 1: Aptazyme catalytic activity assay. Theophylline aptazyme were transcribed in-vitro for 1h30. RNA was analyzed in an 8% polyacrylamide gel with urea. The inactive form of Theophylline aptazyme represents the whole RNA and corresponds to the band of 94 pb. Cleaved aptazyme represents the two parts of the aptazyme Theophylline (18 pb + 76 pb). |
]] | ]] | ||
+ | |||
+ | Inactive aptazyme did not present aptazyme catalytic activity, which confirms their use as an efficient negative control. | ||
+ | |||
+ | To see in-vivo assays results of MS2-MS2-Theophylline-PP7-PP7 aptazymes see <partinfo>BBa_K2923018</partinfo>. | ||
+ | |||
===User Reviews=== | ===User Reviews=== |
Latest revision as of 18:20, 16 October 2019
Introduction
To validate the designed constructs we decided to test Theophylline switch-off (stop auto-cleavage in presence of ligand). For negative control, we choose an inactive form of aptazyme: mutation at the ribozyme domain. iGEM Strasbourg designed construct requires the use of aptazyme linked to MS2 and PP7 stem-loops. The following results described MS2-MS2-Aptazyme-PP7-PP7 activity in in-vitro and in-vivo assays.
In-vitro assay of BBa_K2923019
In order to check MS2-MS2-Theophylline-PP7-PP7 cleavage activities, in-vitro transcription products were analyzed by 2% agarose gel with urea (Figure 1).
![](/wiki/images/b/be/Theo_gel-2.jpg)
Inactive aptazyme did not present aptazyme catalytic activity, which confirms their use as an efficient negative control.
To see in-vivo assays results of MS2-MS2-Theophylline-PP7-PP7 aptazymes see BBa_K2923018.
User Reviews
UNIQf379120f467abbb7-partinfo-00000001-QINU UNIQf379120f467abbb7-partinfo-00000002-QINU